IL34599A - Method of preparing a prothrombin complex - Google Patents

Method of preparing a prothrombin complex

Info

Publication number
IL34599A
IL34599A IL34599A IL3459970A IL34599A IL 34599 A IL34599 A IL 34599A IL 34599 A IL34599 A IL 34599A IL 3459970 A IL3459970 A IL 3459970A IL 34599 A IL34599 A IL 34599A
Authority
IL
Israel
Prior art keywords
polyethylene glycol
prothrombin complex
supernatant
suspension
cohn
Prior art date
Application number
IL34599A
Other languages
English (en)
Other versions
IL34599A0 (en
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of IL34599A0 publication Critical patent/IL34599A0/xx
Publication of IL34599A publication Critical patent/IL34599A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL34599A 1969-06-19 1970-05-26 Method of preparing a prothrombin complex IL34599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83488369A 1969-06-19 1969-06-19

Publications (2)

Publication Number Publication Date
IL34599A0 IL34599A0 (en) 1970-07-19
IL34599A true IL34599A (en) 1973-07-30

Family

ID=25268043

Family Applications (1)

Application Number Title Priority Date Filing Date
IL34599A IL34599A (en) 1969-06-19 1970-05-26 Method of preparing a prothrombin complex

Country Status (13)

Country Link
US (1) US3560475A (fr)
BE (1) BE751667A (fr)
CA (1) CA920058A (fr)
DE (1) DE2029455C3 (fr)
DK (1) DK127676B (fr)
ES (1) ES380950A1 (fr)
FR (1) FR2052987B1 (fr)
GB (1) GB1253339A (fr)
IL (1) IL34599A (fr)
IT (1) IT1043810B (fr)
NL (1) NL170150C (fr)
SE (1) SE397474B (fr)
ZA (1) ZA703574B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4046877A (en) * 1975-07-18 1977-09-06 Syntex (U.S.A.) Inc. Method of increasing immunologic competence
DK144731C (da) 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
WO1981002105A1 (fr) * 1980-01-28 1981-08-06 Baxter Travenol Lab Compositions therapeutiques et procede de fabrication et d'utilisation de celles-ci
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
US5614500A (en) * 1983-03-04 1997-03-25 The Scripps Research Institute Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
ZA877535B (en) * 1986-10-09 1988-04-11 F. Hoffmann-La Roche & Co. Aktiengesellschaft Factor ix-peptides
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
USRE38431E1 (en) * 1995-12-01 2004-02-17 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US6320029B1 (en) 1996-11-29 2001-11-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
JP3944267B2 (ja) * 1996-08-09 2007-07-11 財団法人化学及血清療法研究所 プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
US5770705A (en) * 1996-11-01 1998-06-23 Shanbrom Technologies Llc Method for recovering proteins from plasma using insoluble, water-absorbing material
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
DE602005024955D1 (de) 2004-03-19 2011-01-05 Baxter Healthcare Sa Faktor ixa zur behandlung von blutungsstörungen
CN116194080A (zh) 2020-09-23 2023-05-30 奥姆里克斯生物药品有限公司 止血制剂及其用途

Also Published As

Publication number Publication date
GB1253339A (en) 1971-11-10
DK127676B (da) 1973-12-17
FR2052987A1 (fr) 1971-04-16
NL170150B (nl) 1982-05-03
DE2029455B2 (de) 1978-08-24
US3560475A (en) 1971-02-02
ZA703574B (en) 1971-01-27
DE2029455C3 (de) 1979-04-19
SE397474B (sv) 1977-11-07
IT1043810B (it) 1980-02-29
DE2029455A1 (de) 1971-02-25
FR2052987B1 (fr) 1974-05-24
IL34599A0 (en) 1970-07-19
BE751667A (fr) 1970-11-16
NL170150C (nl) 1982-10-01
CA920058A (en) 1973-01-30
ES380950A1 (es) 1972-10-16
NL7008957A (fr) 1970-12-22

Similar Documents

Publication Publication Date Title
US3560475A (en) Prothrombin complex prepared by precipitation with polyethylene glycol
US3770631A (en) Clarification of blood serum and plasma
US4073886A (en) Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3682881A (en) Fractionation of plasma using glycine and polyethylene glycol
FI57421B (fi) Foerfarande foer framstaellning av ett preparat ur maenniskoblodplasma med blodets koagulation befraemjande verkan
Girolami et al. A ‘new’congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred
Aggeler et al. Plasma throinboplastin component (PTC) deficiency: A new disease resembling hemophilia
US4297344A (en) Blood coagulation factors and process for their manufacture
US5260420A (en) Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
JP3701028B2 (ja) 高純度フォンビルブラント因子の入手方法
Aggeler Physiological basis for transfusion therapy in hemorrhagic disorders: a critical review
US4404132A (en) Blood coagulation promoting product
US3839314A (en) Clarification of blood serum and plasma using block copolymers of ethylene oxide and polyoxypropylene
Mason et al. Some effects of a microcrystalline collagen preparation on blood
WO1992013495A1 (fr) Adhesif a base de fibrinogene
IL42221A (en) Stabilization of ahf
HU214905B (hu) Eljárás VIII. faktor izolálására
Pui et al. Lack of pathogenetic role of proteins C and S in thrombosis associated with asparaginase‐prednisone‐vincristine therapy for leukaemia
JPS6028812B2 (ja) 副作用のない血漿分別物の製造方法
NO316155B1 (no) Forbedret vevslim fremstilt ved anvendelse av kryopresipitat, fremgangsmåtefor fremstilling derav, samt anvendelse av en mengde avproteaseinhibitor
EP0044343A1 (fr) Compositions therapeutiques contenant de la prothrombine et procede de production de facteurs de coagulation du sang agissant enzymatiquement, a partir de fractions sanguines contenant de la prothrombine.
US4361510A (en) Blood coagulation promoting product
Bruning et al. Prothrombal: a new concentrate of human prothrombin complex for clinical use
US3893990A (en) Clarification of blood serum and plasma using a block copolymer of ethylene oxide and polyoxypropylene
EP0052874A1 (fr) Méthode de génération de l'activité procoagulante du facteur VIII